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Oldenlandia diffusa (OD) is commonly used with various diseases such as cancer, arthritis, and autoimmune disease. Liver cirrhosis
is a predominant risk factor for hepatocellular carcinoma (HCC). Here, we show that the therapeutic effect of OD, which was
investigated both in vitro and chemically, induced HCC model. OD significantly enhanced apoptosis and antiproliferative activity
and reduced migration ability of HCC cells. In vivo, OD was treated twice a day for 28 days after confirmed HCC model through
2-[18F]-fluoro-2-deoxy-D-glucose (18F-FDG) imaging. The survival in OD treated groups was shown to have a greater therapeutic
effect than the control group. 28 days after OD treatment, OD treated groups resulted in a significant reduction in tumor number,
size, 18F-FDG uptake, and serum levels such as alanine transaminase, aspartate transaminase, and alkaline phosphate compared to
the control group. Also, proliferated cells in tumor sites by OD were reduced compared to the control group. Furthermore, several
rats in OD treated group survived over 60 days and liver morphology of these rats showed the difference between tumor mass and
normal tissue. These results suggest that OD may have antiproliferative activity, inhibition of metastasis, and apoptotic effects in
chemically induced HCC model and can have the potential use for clinical application as anticancer drug of the herbal extract.
1. Introduction
Hepatocellular carcinoma (HCC) is the fifth most com-
mon cancer and the second leading cause of cancer death
worldwide [1, 2]. HCC can be involved from hepatitis B
or hepatitis C, cirrhosis due to alcohol consumption, liver
disease such as aflatoxin toxicity, hormonal imbalance, and
metabolic disease [3–5]. Various treatment options for HCC
are available clinically, which include surgery, chemotherapy,
and radiotherapy. However, the patients are at high risk in
recurrence and the progressingmechanismofHCC including
long-lasting inflammation in hepatocytes leading to cirrhosis
has not been fully elucidated [6, 7].
A number of studies have reported the beneficial effect of
herbal medicine in diverse diseases such as central nervous
system and cancer. Also, many herbal drugs and prescrip-
tions have in fact been used clinically for the treatment of
cancer and autoimmune diseases. Several studies reported
anticancer activity in vitro and in vivo using natural herb
extract [8–10]. Recently, an extract isolated from medicinal
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herb such as Oldenlandia diffusa (OD) has intrigued interest
because of its anticancer and chemoprevention effect on
various cancer and normal cells [11, 12].
OD is a well-known medicinal plant used in Korean
and Chinese herbal medicine for the treatment of hepatitis,
tonsillitis, urethral infection, and malignant tumors of the
liver and lung. A number of studies have reported multiple
biological activities of the OD such as antitumor, chemo-
preventive, anti-inflammatory, antioxidant, and proapoptotic
effect [13, 14]. However, themechanism behind the antitumor
effect of OD is still largely unknown and has certainly not
been evaluated in chemically induced liver cancer. OD is
identified to include oleanolic acid (3b-hydroxyolean-12-
en-28-oic acid, OA), ursolic acid (3b-3-hydroxyurs-12-ene-
28-oic acid, UA), asperuloside (IG1), E-6-O-p-coumaroyl
scandosidemethyl ester (IG2), andE-6-O-p-coumaroyl scan-
dosidemethyl ester-10-methyl ether (IG3). OA has an isomer,
UA, which is also a pentacyclic triterpenoid compound.
OA and UA are distinguished by the position of methyl
group between C19 and C20. It has also been reported that
dexamethasone, which is a glucocorticoid hormone that has
a structure similar to OA andUA. AlthoughOA andUA have
similar structure,OAhas effects such that the inhibitory effect
of OA on cytochrome P450 is stronger than UA [15]. Also,
OA and UA exhibit significant antitumor effect and cytotoxic
activity in many cancer cell lines such as liver cancer cells,
gastric cancer cells, colon carcinoma cells, and fibrosarcoma
cells [11, 16–20].
In this study, we investigated the ability of OD enhanced
anticancer effect in apoptotic cell death, inhibition of pro-
liferation, and migration of HCC cell lines. In addition, we
were able to demonstrate OD enhanced antitumor effects
in regulation of hepatic function, glucose metabolism, and
metastasis in chemically induced liver cancer model.
2. Materials and Methods
2.1. Preparation of Oldenlandia diffusa (OD), Oleanolic Acid
(OA), and Ursolic Acid (UA). The herbal sample of OD Roxb
was purchased from an herbal market in Gyeongdong. OD
was extracted using reflux extraction equipment in hot water
for an hour and concentrated using a rotary evaporator before
lyophilization. OA and UA were purchased from Sigma-
Aldrich (St. Louis,MO,USA).The compoundswere dissolved
in DMSO and the final concentration of DMSO in samples
was 0.15%.
2.2. Cell Culture. Liver cancer cell lines such as huh7 and
hepG2 were obtained from the American Type Culture Col-
lection (ATCC; Manassas, VA, USA, http://www.atcc.org).
The cells were maintained in Dulbecco’s Modified Eagle’s
Medium (DMEM; Hyclone, Logan, UT, USA). The huh7 and
hepG2 cells were supplemented with antibiotics and 10% of
fetal bovine serum (FBS; HyClone). Cells were incubated at
37∘C in a humidified atmosphere containing 5% CO
2
.
2.3. Cell Viability Assay. Cell viability was measured using a
Cell Counting Kit-8 (CCK-8; Dojindo Laboratories) allowing
sensitive colorimetric assay by using highly water-soluble
tetrazolium salt that is reduced by dehydrogenases in living
cells to give a colored product (formazan). The cells were
seeded in 96- (5 × 103 cells/well) or 24-well plates (2 ×
104 cells/well) in medium containing 10% FBS and were
incubated for 24 h. Subsequently, cells were treated with
medium containing OA (0–100 𝜇g/mL), UA (0–100 𝜇g/mL),
and OD (0–500mg/mL) at 37∘C for 24 h. The untreated
cells in medium containing 0.15% DMSO were used as 100%
viability controls.The cells withCCK-8were incubated for 2 h
and were thenmeasured at 450 nmwith a spectrophotometer
(Molecular Devices, Sunnyvale, CA, USA).
2.4. Scratch-Induced Migration Assay. To investigate the
effect of OD, OA, and UA on the migration of HCC
cells, a scratch-induced migration assay was performed. The
cells were seeded in 6-well plates (1 × 105 cells/well) and
maintained in DMEM with 10% FBS. The monolayer cells
were scraped by using the tip of a 200 𝜇L micropipette,
creating linear streaks 2mm apart. Cells were washed twice
with medium to remove nonadherent cells and were further
incubated in fresh medium with 10% FBS containing OD
(200mg/mL), OA (100 𝜇g/mL), and UA (50 𝜇g/mL) for 48 h.
Wound closure or cell migration was photographed at 0,
24, and 48 h after wounding, using an inverted microscope
equipped with digital camera (Nikon, Tokyo, Japan). The
images were analyzed into the Meta-Morph imaging soft-
ware (Molecular Devices Inc., Downingtown, PA, USA). For
statistical analysis, at least three independent scratch wound
experiments were used for calculations.
2.5. Real Time Polymerase Chain Reaction Analysis. Total
RNA was extracted from cancer cells using RNeasy Mini Kit
(Qiagen, Valencia, CA). cDNA was synthesized with total
RNA and oligo(dT) primer (Invitrogen, Carlsbad, CA) using
Omniscript RT kit (Qiagen) for real time polymerase chain
reaction (RT-PCR). The cDNA samples were diluted 20-fold
with water and were used as templates for RT-PCR with 2×
SYBRGreenMasterMix and oligonucleotide primers. Quan-
titative RT-PCR was performed using theMyiQ Single-Color
RT-PCR Detection System (TaKaRa, Shiga, Japan). Details
of the primers are described in the Supporting Informa-
tion (Supplementary Table 1) (see Supplementary Materials
available online at http://dx.doi.org/10.1155/2015/501508). RT-
PCR was conducted as described previously [21]. Standard
PCR conditions were 95∘C (5min) and then 40 cycles of
94∘C (10 s), 60∘C (20 s), and 72∘C (15 s), followed by the
standard denaturation curve with 0.5∘C increment for 70
cycles. The ΔCt method was used to calculate the relative
levels of expression. The threshold cycle (Ct) value from
triplicate measurements was calculated for the expression of
the target gene and normalized to that of GAPDH.
2.6. Animal Model. The experimental protocols used in this
study were designed according to the animal experimental
guidelines established by the Institutional Animal Care and
Use Committee of Catholic University Medical School. The
HCC model procedure was performed as described previ-
ously [22, 23]. To induce HCC model, male Sprague-Dawley
(180–200 g) rats received intraperitoneal injections of DEN
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(50mg/kg; Sigma, St. Louis, MO, USA) once a week for
16 weeks. We confirmed successful development of HCC
through PET/CT scan at the last DEN injection.
2.7. Experimental Groups and Therapeutic Efficacy Study.
Animalswere assigned randomly to one of the following three
major groups: (1) one group of rats was treated with distilled
water as control group (𝑛 = 9), (2) the second group was fed
with OD (100mg/kg; 𝑛 = 9), and (3) the third group was fed
with OD (200mg/kg; 𝑛 = 9). To assess the survival of the OD
treated animals, rats were randomized (𝑛 = 9, for each group)
after last DEN injection and were treated with OD twice a
day for 28 days. We recorded starting from day 0 after OD
treatment. Survival was followed for a maximum of 60 days.
2.8. PET/CT Imaging and Data Analysis. PET/CT imaging
and data analysis were performed as previously reported
[24, 25]. Images were taken at 0 and 28 days after the
OD treatment with a PET scanner using a General Electric
Discovery STE (Waukesha, WI, USA). The rats were deeply
anesthetized with ketamine and xyzine and 18F-FDG (1.1 ±
0.04mCi) was injected intravenously into the caudal vein.
After 30min, the rats were taken using a PET/CT scanner and
body temperature was kept at 37∘C with a heating pad on the
scanner bed.
To assess the changes of 18F-FDG uptake, regions of
interest (ROIs) in the lesioned areas were identified in images
of the coronal and horizontal sections. Each ROI value was
defined on the coronal tomograms that showed the highest
uptake to be in the middle of the tumor and calculated as
the averaged nCi/cc after calibration of both liver of insulated
areas and muscle in the same images. We expressed the
standard uptake value (SUV) in ROIs values.
2.9. Liver Function Tests. To test liver function, we examined
the serum levels of alkaline phosphatase (ALP; Siemens),
aspartate transaminase (AST; Siemens), and alanine transam-
inase (ALT; Siemens, USA) 28 days after OD treatment.
Briefly, the blood samples were collected before sacrifice and
centrifuged at 3000 rpm for 20min. The supernatant was
analyzed to quantify the concentration in strict accordance
with the manufacturer’s protocols.
2.10. Macroscopic and Microscopic Observation. Four weeks
after the last DEN injection, all group rats (𝑛 = 5, for
each group) were deeply anesthetized with 15% urethane and
sacrificed by decapitation. The whole liver tissue was sliced
into 2mm thickness. The tumors were counted by macro-
scopic examination of the liver through two independent
investigators according to the criteria.
2.11. Histological Examination. 28 days after OD treatment,
animals from each group were sacrificed for histological
examination. The tissue was cut coronally at a thickness of
4 𝜇m from each rat for a total of three blocks. The paraffin
sections were dewaxed in histoclear and rehydrated through
a grade alcohol series.The slides were incubatedwith primary
antibody against mouse antiproliferating cell nuclear antigen
(PCNA; Millipore, Billerica, MA, USA) at 4∘C overnight.
Subsequently, slides were incubated in Alexa 546-conjugated
goat anti-mouse IgM (Molecular probe, Eugene, Oregon,
USA). The slides were counterstained with 4󸀠,6-diamidino-
2-phenylindole (DAPI; Sigma-Aldrich) and detected using
a Zeiss LSM510 confocal microscope (Carl Zeiss, Jena, Ger-
many).
2.12. Statistical Analysis. All data are presented as mean
values ± standard deviation from at least 3 independent
experiments. Statistical differences between different test
conditionswere determinedusing Student’s t-test. Probability
values less than 0.05 were considered statistically significant.
Also, the statistical analysis of survival was carried out using
a log-rank test.
3. Result
3.1. Anticancer Effect of Oldenlandia diffusa (OD) in Hepa-
tocellular Carcinoma (HCC) Cells. First, we determined the
antitumor effect of OD including cytotoxicity and growth
inhibitory effect in hepatocellular carcinoma cells such as
huh7 and hepG2. OD treatment exhibited a cytotoxic effect
in a dose-dependent manner (Figure 1(a)). Based on these
results, we chose OD concentration of 200mg/mL for the
following in vitro experiments. We treated HCC cells with
OD for 72 h and assessed the number of viable cells. We
showed that OD has time dependent growth inhibitory effect
(Figure 1(b)). Also, we observed caspase-3 and ki67 through
immunostaining (Figure 1(c)). In OD treatment, the activity
of ki67-positive cell of HCC cells was decreased and the
activation of caspase-3 was significantly increased compared
to the control (Figure 1(d)).We questioned what components
of OD have antitumor effects inHCC cells. Numerous studies
have reported that the principal component in OD including
OA andUA could have antitumor effects.We showed that OA
and UA have antitumor effects in HCC cells (Supplementary
Figure 1). These results suggest that OD has an antitumor
effect via the antiproliferation activity and apoptosis of OA
and UA in HCC cells.
3.2. Suppression of HCC Cell Migration by OD. To examine
the effect of OD on cell migration, we performed the scratch
wound healing assay using the huh7 and hepG2 cells. All
wound healing images are at the samemagnification and time
after OD treatment. At 48 h, the wound of FBS treatment
was healed approximately 65% ± 13% in huh7 and 53.4%
± 11% in hpeG2 cells from the positive-control cells. OD
significantly reduced cell motility in both huh7 (OD: 36.8%
± 6%) and hepG2 (OD: 37.4% ± 4%) compared to the FBS
treatment (Figure 2). Furthermore, we showed that OA and
UA treatment reducedwoundhealing (Supplementary Figure
2). We also measured mRNA for migration related receptors
such as CXCR1, CXCR2, and CXCR4 in HCC cells by OD,
OA, andUA.The expression ofmigration related receptorwas
significantly decreased by OD, OA, and UA compared to the
FBS treatment (Figure 2(c); Supplementary Figure 2). These
results suggested that the OD could inhibit the migration in
HCC cells through inhibition of migration receptors by OA
and UA.
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Figure 1: The antitumor effect on hepatocellular carcinoma (HCC) cell lines treated with Oldenlandia diffusa (OD). The cytotoxic effect and
antiproliferative activity were measured by CCK-8 cytotoxicity assay and immunoreactive cells such as Ki67 and caspase-3. The cytotoxicity
effect on HCC cell lines treated with the indicated concentrations of OD (0–500mg/mL) for 24 h (a). Also, we measured antiproliferative
activity of OD (200mg/mL) against HCC cells for 72 h (b). Ki67 and caspase-3 staining were performed after 24 h in OD (200mg/mL)
((c), (d); scale bars, 100 𝜇m). OD treatment in huh7 and hepG2 cells reduced ki67-positive cells and increased caspase-3 immunoreactivity.
Columns, mean; bar, SE. Student’s 𝑡-test, ∗𝑃 < 0.05 and ∗∗𝑃 < 0.01.
3.3. Survival and Uptake of 18F-FDG in HCC Model by OD.
Before treating OD, we confirmed HCC model using the
PET/CT imaging.We recorded starting fromday 0 beforeOD
treatment and observed the survival rate of rats. 50% of rats in
control group died between 20 days and 30 days (Figure 3(b)).
The last rat of control group was dead after 36 days. However,
the rats of OD treated group (100 and 200mg/kg) survived
more than 40% (Figures 3(a) and 3(b)). Also, 30% of rats in
OD treated group (200mg/kg) survived more than 50 days.
PET/CT imaging was performed on day 0 and day 28. 18F-
FDG has long been demonstrated to be a marker of glucose
metabolism in cirrhosis and tumor.The specific areas of liver
identified with increased uptake of 18F-FDG in PET imaging
(Figure 3(c)) and the quantitative image analysis of 18F-FDG
revealed the SUV (Figure 3(d)).The SUV value of liver in OD
treated group (100 and 200mg/kg) was lower in certain areas
compared to the control group (control: 132.0 ± 11.7; OD
100mg/kg: 112.5 ± 7.2; OD 200mg/kg: 108.8 ± 5.7).
3.4. Reduction for Number of Tumors and Levels of ALT, AST,
andALP in SerumbyOD. We investigatedwhetherODcould
change hepatic function related factors including ALT, AST,
and ALP on serum level in DEN-induced HCC model. We
collected serum 28 days after OD treatment and analyzed
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Figure 2: The migration effect of HCC cells by OD. Effect of OD on cell migration by scratch wound migration assay ((a), (b), and (c)). 10%
FBS containing DMEM was used as an experimental control. At 48 h after scratching, cell migration is suppressed significantly in huh7 and
hepG2 by OD (200mg/mL) (c). OD influences the expression of migration related receptor including CXCR1, CXCR2, and CXCR4 (d) for
24 h. Columns, mean; bar, SE. Student’s 𝑡-test, ∗𝑃 < 0.05 and ∗∗𝑃 < 0.01.
component of related liver function. Also, a comparison was
made by categorizing the tumor number by tumor size and
measured the liver/body ratio 28 days after OD treatment.
The serum ALP, AST, and ALT levels in OD treated group
(100 and 200mg/kg) were significantly lower compared to
the control group (Figure 4(a)). Also, the size distribution of
nodules and the liver/body ratio in OD treated group (100
and 200mg/kg) were significantly reduced compared to the
control group (Figures 4(b) and 4(c)). These results suggest
that OD may regulate the development and metastasis in
tumors by enhancing hepatic function.
3.5. Suppression of Tumor Cell Proliferation and Metastasis
by OD. To investigate the inhibitory effect of OD on the
proliferation in tumor cells, we performed immunostaining
in PCNA, which is a cell proliferation marker. In OD group,
PCNA-positive cells were significantly decreased compared
to the control group (Figure 5). Also, we observed the hepatic
morphology of rats more than 60 days after OD treatment.
60 days after OD treatment (200mg/kg), the large tumor was
observed in two sites (Figure 6(a)). Except for tumor site, the
rest of the liver tissue was similar in morphology to the nor-
mal liver. We think that this is very interesting result because
of numerous developments ofmultinodularHCC and cirrho-
sis in chemically inducedHCCmodel. Also, the percentage of
liver/body weight ratios in rats 28 days and 60 days after OD
treatment (200mg/kg)was not significantly different (Figures
4(c) and 6(b)). Furthermore, we demonstrated a significant
tumor growth including malignant nodules over 3mm of a
diameter, cirrhosis, and necrosis using the H&E staining at
28 days in control group (Figures 6(c)–6(f)). 60 days after
OD treatment (200mg/kg), a boundary line between the
large tumor and normal liver cells was observed (Figures
6(g)-6(f) and 6(k)–6(m)), as well as normal hepatocellular
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Figure 3: The therapeutic effects of OD for survival and glucose metabolism after HCC. Experimental scheme to test the effect of OD on
the survival or 18F-FDG uptake in HCC model (a). The survival of HCC was analyzed by a log-rank test based on the Kaplan-Meier method
(b). We recorded starting from day 0 after the last DEN injection. We record death rate between 20 days and 36 days (c). 18F-FDG PET was
scanned at day 0 and 28 days after OD treatment. At 28 days after OD treatment, liver of rats in control group was significantly enhanced
uptake of 18F-FDG into generated HCC and showed multinodular HCC. However, uptake of 18F-FDG on rat’s liver in OD (100 and 200mg)
treated group was decreased compared to the control group (d). Quantitative analysis of 18F-FDG uptake analyzed at day 0 and 28 days after
OD treatment (e). The relative SUV of OD treated group was decreased compared to the control group. Columns, mean; bar, SD. ∗𝑃 < 0.05.
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Figure 4: The analysis of level on serum, tumor number categorized by tumor size, and assessment of the liver/body weight 28 days after
OD treatment. The blood samples were collected 28 days after OD treatment and the serum level of ALP, AST, and ALT was measured (a).
Comparison of tumor number was categorized by tumor size 28 days after OD treatment (b). Also, liver/body weight ratio was measured 28
days after OD treatment. The serum levels of ALP, AST, and ALT in OD treated group were significantly decreased compared to the control
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Figure 5: Inhibition of tumor cell proliferation by OD. Histological analysis was shown in PCNA-positive cells 28 days after OD treatment
((a) scale bars, 100𝜇m). Quantification of PCNA-positive cells in the tumor area (b).The proliferated cells were significantly decreased in the
OD treated group (100 and 200mg/kg) compared to the control group. Columns, mean; bar, SD. ∗∗𝑃 < 0.01.
8 Evidence-Based Complementary and Alternative Medicine
g
k
k
g
6
0
da
ys
 aft
er
 O
D
 (2
0
0
m
g)
 tr
ea
tm
en
t
(a)
0
1
2
3
4
Li
ve
r/
bo
dy
 w
ei
gh
t (
%
)
5
6
7
60 days
OD (200mg)
(b)
dt
t
t
(c)
e
ft
(d)
t
(e) (f)
h
t
(g)
i
j
t
(h)
t
(i) (j)
l
t
(k)
m nt
(l)
t
(m) (n)
Figure 6: Liver morphology, liver/body ratio, and histopathology analysis 60 days after OD treatment. Liver/body weight ratio was measured
after last OD treatment (200mg/kg). Liver morphology was shown 60 days after OD treatment (200mg/kg) and H&E staining was done.
The large tumor observed in two sites (a). Except for tumor site, the rest of the liver tissue was similar to the normal liver morphology.
OD (200mg/kg) inhibits metastasis of tumor. Liver/body weight ratio in rats 60 days after OD treatment (b). The liver/body ratio after OD
treatment (200mg/kg) was not different between 28 days and 60 days (columns, mean; bar, SD). We show that tumor growth including the
malignant nodules over 3mm of a diameter, cirrhosis, and necrosis in tumor were significantly progressing in slides at 28 days in control
group ((c)–(f)). 60 days after OD treatment, we observed the boundary between the large tumor and normal liver cells ((g)-(f), (k)–(m)).
Also, no cirrhosis was shown and normal liver cells exist ((j), (n)). Scale bars ((a), (g), and (k)); 5mm ((d), (h), and (l)); 500 𝜇m ((e)-(f), (i)-(j),
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architecture (Figures 6(j) and 6(n)).These results suggest that
OD (200mg/kg) may inhibit the ability of cell proliferation
and metastasis of tumor through enhanced hepatic function.
4. Discussion
Herbal medicine has been used in Asian countries and
numerous studies have reported anticancer activity in vitro
using a natural herb extract [8, 26]. OD, a traditional Chinese
and Korean medicinal plant, is known for its anticancer
activities [14, 27, 28] and is a valuable medicinal plant for
its multipurpose uses. However, the mechanism of antitumor
effect of OD is still largely unknown and has not been
evaluated in chemically induced liver cancer. In this study,
we investigated the anticancer effect of OD on chemically
induced liver cancer model. Also, we studied the anticancer
effect of OD such as apoptosis, cell proliferation, and migra-
tion of HCC cells including huh7 and hepG2 and elucidated
possible mechanisms.
This study demonstrated that OD induced apoptosis by
caspase-3 pathway in HCC cells. Also, OD suppressed pro-
liferation of HCC cells compared to untreated control cells.
These results were consistent with previous findings of anti-
cancer effect in breast cancer cells [14]. Since HCC exhibits
a high rate of metastasis, it would be of great importance to
understand the migration receptor related gene expression
that affects the process of HCC metastasis. We were able to
demonstrate the effect of OD in inhibiting cell migration
in HCC cells and reducing expression of migration related
chemokine receptors such as CXCR1, CXCR2, and CXCR4.
BothCXCR1 andCXCR2 are predominantly expressedwithin
the immune system and bind with the highest affinity to the
chemokine interleukin-8. CXCR1 and CXCR2 can mediate
migration, invasion, and proliferation individually in can-
cer cells [29]. CXCR4, known as SDF-1𝛼 receptor, plays a
critical role in normal physiology as well as the pathology
of many human diseases including cancer, inflammation,
and autoimmune disease. Also, CXCR4 correlates with the
histological grade and invasive capacity of tumor cells, as
well as with tumor cell survival [30]. Our results suggest
that OD has anticancer effect in caspase-3 induced apoptosis,
antiproliferation, and the inhibition of migration. However,
we do not know the exact mechanism of OD as OD consists
of numerous compounds. We hypothesized that the prin-
cipal component in OD including OA and UA could have
antitumor effects. The OA and UA are present in OD at
high abundance and are pentacyclic triterpenoids that exist
widely in plants [31, 32]. OA and UA share similar chemical
structure and the only difference of the two compounds is
the position of one methyl group between C19 and C20. Our
results show OA and UA inhibit cell proliferation of huh7
and hepG2. Also, OA and UA induce apoptosis involving
mitochondrial pathway through caspase-3 activation and
reduced expression of migration related receptors such as
CXCR1, CXCR2, and CXCR4. Our results suggest that OA
and UA presented in OD at high abundance can play critical
roles of anticancer effects.
We investigated the anticancer effect of OD in in vivo
model using the chemically induced liver cancer model.
We employed a DEN-induced cancer model which can
establish HCC and liver cirrhosis simultaneously as the
malignant tumor progresses from liver cirrhosis. This model
may provide similarity between experimental and human
HCC and be a better scheme for studying human HCC than
the implanted HCC model with cirrhosis. The survival in
vivo experiment revealed that OD enhances survival rate
compared to the control group. Also, 30% of rats in OD
treated group survived more than 50 days. 18F-FDG can
provide a useful indicator of tumor growth and metastasis
because 18F-FDG accumulates in tumor mass with increased
glucose metabolism [33]. Also, 18F-FDG imaging can pro-
vide additional information including tumor development
and secondary tumor growth. In a previous study, we
have reported that we analyzed 18F-FDG imaging using
the PET/CT time-dependently in DEN-induced liver cancer
model. We analyzed 18F-FDG imaging at day 0 and day 28.
The uptake of 18F-FDGof liver inOD treated groupwas lower
in certain areas compared to the control group. Furthermore,
OD can change hepatic function related factors including
ALT, AST, and ALP on serum level in HCC model. Serum
components such as ALT, AST, and ALP are markers of
hepatic function and their increases in blood indicate liver
damage by the cytotoxic effects of DEN [34, 35].
Our results show that OD may regulate glucose
metabolism in tumors through enhancing hepatic function.
Also, these results show similar pattern as reduction of the
number categorized by tumor size, liver/body ratio, and cell
proliferation in tumors. We investigated liver morphology,
tumor number, and size of rats that survived more than
60 days after OD treatment. We observed the large tumor
in two sites. Except for tumor site, the rest of the liver
tissue was similar in morphology to normal liver, despite
the chemically induced HCC model generating numerous
tumors and cirrhosis in the liver (Figure 4(b)). This is an
interesting finding suggesting that OD may have a role in
enhancing the hepatic function and inhibiting the metastasis
in chemically induced HCC model. In the pathology
analysis, we observed normal hepatocellular architecture in
the boundary around the tumor site. Also, the liver/body
weight ratio in rats 28 days and 60 days after OD treatment
was not different. These results suggest that OD inhibits the
ability of cell proliferation and tumor metastasis through the
regulation of hepatic function, glucose metabolism, and the
migration related receptors.
In conclusion, this study demonstrated that OD treat-
ment has anticancer effects in inhibiting the growth of HCC
cell in chemically induced liver cancer model. Also, OD
can regulate the hepatic function and glucose metabolism.
Furthermore, our results have shown thatOA andUAderived
from OD extracts act as the bioactive components of the
anticancer effects. Further studies are needed to identify the
detailedmechanisms involved in the therapeutic effect of OD
in vivo.
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